中药中多环芳烃污染风险控制研究进展  

Research Progress on Risk Control of Polycyclic Aromatic Hydrocarbons in Traditional Chinese Medicine

作　　者：杜晓娟 曾利娜 苏畅 王铁杰 金红宇[2] 魏锋[2] 马双成[2] 王淑红 DU Xiao-juan;ZENG Li-na;SU Chang;WANG Tie-jie;JIN Hong-yu;WEI Feng;MA Shuang-cheng;WANG Shu-hong(Shenzhen Institute for Drug Control,Shenzhen 518057,China;National Institutes for Food and Drug Control,Beijing 100050,China)

机构地区：[1]深圳市药品检验研究院,广东深圳518057 [2]中国食品药品检定研究院,北京100050

出　　处：《中国现代中药》2021年第4期741-746,共6页Modern Chinese Medicine

基　　金：国家药典委员会药品标准制修订研究课题(2020Z16)。

摘　　要：中药是人们防病治病的特殊商品,不仅具有有效性,更要保证使用安全。中药中外源性有害物质残留一直广受关注,其中环境污染、不规范的中药炮制加工等因素容易导致多环芳烃残留,对中药质量安全和中药国际化的影响不容忽视。对中药中多环芳烃的来源、分布、危害和检测分析等方面的研究进展进行综述,为进一步探索和加强中药质量安全控制提供参考。Traditional Chinese medicine(TCM)is a special commodity for people to prevent and treat diseases,which is not only the effectiveness,but also safe to use.The residue of exogenous harmful substances in TCM has been widely concerned,environmental pollution,non-standard processing of TCM and other factors lead to the residue of polycyclic aromatic hydrocarbons,which have an impact on the quality and safety of TCM and the internationalization of TCM can not be underestimated.The source,distribution,harm,detection and analysis of polycyclic aromatic hydrocarbons in TCM were summarized and analyzed in order to provide reference for further strengthening the quality and safety control of TCM.

关 键 词：中药 外源性有害物质残留 多环芳烃 风险评估 

分 类 号：R284[医药卫生—中药学]